drugset / Trial / NCT02624180

Inflammatory Pathogenesis of Coronary Atherosclerosis in HIV

NCT02624180

RandomizedParallel-groupQuadruple-blindOther

Summary

The investigators are studying whether an anti-inflammatory intervention improves impaired coronary endothelial function (CEF) in HIV+ people with no clinical coronary artery disease (CAD).

Timeline

Start
2015-11
Primary completion
2020-08-01
Completion
2020-09-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Colchicine Small molecule 0.6 mg Oral